Welbeck Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 2.60 M
- Company Age 37 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 0.85 M
- Revenue Growth 4.28%
- Profit Growth 32.10%
- Ebitda 194.60%
- Net Worth -9.21%
- Total Assets 6.39%
About Welbeck Pharmaceuticals
Welbeck Pharmaceuticals Private Limited (WPPL) is a Private Limited Indian Non-Government Company incorporated in India on 10 September 1987 and has a history of 37 years and five months. Its registered office is in Delhi, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 2.60 M.
The company currently has active open charges totaling ₹0.85 M.
Veena Anand, Nazir Tali, and Ashok Anand serve as directors at the Company.
Company Details
- Location
Delhi, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U74899DL1987PTC029176
- Company No.
029176
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
10 Sep 1987
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
What products or services does Welbeck Pharmaceuticals Private Limited offer?
Welbeck Pharmaceuticals Private Limited offers a wide range of products and services, including Respiratory System Drugs, Anti Asthma Drug.
Who are the key members and board of directors at Welbeck Pharmaceuticals?
Board Members (3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Veena Anand  | Director | 10-Sep-1987 | Current |
| Nazir Tali | Director | 10-Sep-1987 | Current |
| Ashok Anand | Director | 01-Feb-1991 | Current |
Financial Performance of Welbeck Pharmaceuticals.
Welbeck Pharmaceuticals Private Limited, for the financial year ended 2020, experienced modest growth in revenue, with a 4.28% increase. The company also saw a substantial improvement in profitability, with a 32.1% increase in profit. The company's net worth dipped by a decrease of 9.21%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Welbeck Pharmaceuticals?
In 2019, Welbeck Pharmaceuticals had a promoter holding of 96.85% and a public holding of 3.15%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹0.85 M
₹0
Charges Breakdown by Lending Institutions
- The Jammu And Kashmir Bank Limited : 0.09 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 05 Mar 2008 | The Jammu And Kashmir Bank Limited | ₹0.85 M | Open |
How Many Employees Work at Welbeck Pharmaceuticals?
Welbeck Pharmaceuticals has a workforce of 2 employees as of Apr 04, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Welbeck Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Welbeck Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.